PATENT CLAIM ANALYSIS

Application Number: 15755636
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "243000"]

Abstract:
The invention relates generally to compounds that modulate the activity of TGFBETA R-1 and TGFBETA R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 9):
A pharmaceutical composition which comprises a compound according to  claim 1  or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable carriers, diluents or excipients.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.45161
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15747843', '14977709', '15430883', '14190477', '15746597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609595391387161
- 35 USC 102 Novelty (BERT): 0.5501758243657079
- Combined Prediction Score: 0.7398811676614152
- Mean Citation Score: 304.519028
- Max Citation Score: 385.2536
- Similarity Product: 383.1605313025474

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test